X-37
X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover novel drug candidates by screening vast libraries of chemical compounds against high-value pharmaceutical targets.
X-37
Industry:
Artificial Intelligence Health Care Pharmaceutical
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.x37.ai
Total Employee:
1+
Status:
Active
Contact:
(650) 273-5748
Email Addresses:
[email protected]
Total Funding:
14.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag
Similar Organizations
Current Employees Featured
Founder
Investors List
Hemi Ventures
Hemi Ventures investment in Series A - X-37
DCVC Bio
DCVC Bio investment in Series A - X-37
Alpha Intelligence Capital
Alpha Intelligence Capital investment in Series A - X-37
DCVC Bio
DCVC Bio investment in Seed Round - X-37
Official Site Inspections
http://www.x37.ai
- Host name: 209.182.198.8
- IP address: 209.182.198.8
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "X-37"
X37 is Drug Development At The Speed of AI
Our AI-driven approach to drug development lets us work on the most difficult-to-target proteins across the broadest possible chemical space.See details»
X-37 - Crunchbase Company Profile & Funding
X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover novel drug candidates by screening …See details»
New Atomwise offshoot X-37 raises $14.5M to shepherd AI …
Nov 14, 2019 Molecule prospector Atomwise co-founded a drug research company alongside Velocity Pharmaceutical Development designed to shepherd its artificial intelligence-derived …See details»
X-37 Company Profile 2024: Valuation, Funding & Investors
X-37 General Information Description. Developer of a drug development platform designed to facilitate the discovery of various medicines for patients. The company's platform uses artificial …See details»
Science - X37
X-37 combines the power of AtomNet with the capabilities of a team of seasoned and successful drug developers to bring promising small molecules into clinical development. OUR …See details»
X-37 - Company info. interviews, news - biopharmatrend.com
X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover novel drug candidates by screening …See details»
X-37 Closes $14.5 Million Financing for AI-Enabled Drug Discovery
Nov 14, 2019 Artificial intelligence-enabled drug discovery startup X-37, LLC, announced it has closed $14.5 million in Series A funding to expand its drug development programs and …See details»
X-37 Company Profile - Office Locations, Competitors, Revenue
X-37 is a pharmaceutical discovery and development company. It uses an AI platform to discover drug candidates by screening libraries of chemical compounds against pharmaceutical targets. …See details»
X-37 Announces $14.5 Million Series A - Business Wire
Nov 14, 2019 X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc., to screen vast libraries of …See details»
X-37 Company Profile: AI, Investments, Contact Information, News ...
X-37 AI / ML Service Artificial intelligence Financial Technology Business (B2B) 4 more X37 is Drug Development At The Speed of AI Drugging the Undruggable Our AI-driven approach to …See details»
X-37 - LinkedIn
Employees at X-37 Vinit B. Mahajan Stanford University Professor of Ophthalmology, Vice Chair for Research, Biotechnology Consultant, Co-founder, Member of Startup Advisory Boards…See details»
Research programme: factor XIIa inhibitors - X-37 - AdisInsight
Small molecule inhibitors of factor XIIa are being developed by X-37 for the treatment of anticoagulation disorders (blood ... X-37 is available for licensing as of 27 Nov 2019. …See details»
Top 10 AI Associations
Jun 28, 2023 Whether you are an AI enthusiast, a professional in the industry, or simply curious about the latest advancements, this compilation offers valuable insights into the leading …See details»
Who’s responsible for responsible AI? (It’s a trick question.)
#2: Know your organization’s responsible AI guidelines . To effectively govern AI use in your organization, evaluate your security, ethics and privacy policies. Identify areas where these …See details»
Paris dreams of becoming the capital of positive AI with the ...
22 hours ago After the Olympic Games, artificial intelligence (AI)? Paris intends to attract global attention once again with the Summit for Action on AI, to be held at the Grand Palais. On …See details»
Company AI Policy: Why your business needs one immediately
23 hours ago AI governance signals to stakeholders—whether customers, regulators, or employees—that your organization takes responsible AI use seriously. For Customers: It …See details»
How Artificial Intelligence Can Improve Organizational ... - Forbes
Aug 23, 2022 Artificial intelligence (AI) is reimagining the business world, boosting innovation and productivity, and helping organizations think bigger. Organizations can use AI to improve …See details»
AI to unlock more capabilities for organizations - Google AI
Generative AI and AI agents are changing how organizations operate and customers engage. Google Cloud is at the forefront of this shift, empowering hundreds of organizations to build …See details»
Creating an AI-Ready Organization with Microsoft Copilot
Jul 15, 2024 An organization’s commitment to responsible AI usage will ultimately shape the success of its implementation and influence the overall perception of AI tools within the …See details»
AI at work: A practical guide to implementing and scaling new tools
6 days ago Generative AI is here and it’s not going away – so how can companies successfully implement and scale new tools among workforces? For a new report, the World Economic …See details»